project id: TCGA-KIRP; case submitter id: TCGA-F9-A4JJ; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.48; rna integrity number: 9.2; age at index: 35; days to birth: -12893; days to death: 325; ethnicity: not reported; gender: female; race: black or african american; vital status: Dead; year of birth: 1977; age at diagnosis: 12893; ajcc clinical m: MX; ajcc clinical n: NX; ajcc clinical stage: Stage III; ajcc clinical t: T3a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage III; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 97.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 175; days to sample procurement: 0; initial weight: 1180.0; portion submitter id: TCGA-F9-A4JJ-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0;